Miyanaga Akihiko

ミヤナガアキヒコ | Miyanaga Akihiko

Affiliation and department：

Research field (2)： Tumor diagnostics and therapeutics , Respiratory medicine

Research keywords (2)：臨床腫瘍学 , 呼吸器内科学

Research theme for competitive and other funds (3)：

2020 - 2023 肺癌の発癌・転移に関わる肺Microbiomeの同定と免疫療法との関連性の解明
2019 - 2022 Serum-derived exosomal microRNA predicts the response to immune checkpoint inhibitors cancer in lung cancer patients
2014 - 2018 Identification of the genomic landscape in pulmonary neuroendocrine tumor

Papers (131)：

Takeru Kashiwada, Ryotaro Takano, Fumihiko Ando, Shoko Kuroda, Yoshishige Miyabe, Ryuji Owada, Akihiko Miyanaga, Tomoko Asatsuma-Okumura, Masaaki Hashiguchi, Yoshikazu Kanazawa, et al. Lysosomal degradation of PD-L1 is associated with immune-related adverse events during anti-PD-L1 immunotherapy in NSCLC patients. Frontiers in Pharmacology. 2024. 15
Fumihiko Ando, Takeru Kashiwada, Shoko Kuroda, Takenori Fujii, Ryotaro Takano, Yoshishige Miyabe, Shinobu Kunugi, Takashi Sakatani, Akihiko Miyanaga, Tomoko Asatsuma-Okumura, et al. Combination of plasma MMPs and PD-1-binding soluble PD-L1 predicts recurrence in gastric cancer and the efficacy of immune checkpoint inhibitors in non-small cell lung cancer. Frontiers in Pharmacology. 2024. 15
Joshua K Stone, Natalia von Muhlinen, Chenran Zhang, Ana I Robles, Amy L Flis, Eleazar Vega-Valle, Akihiko Miyanaga, Masaru Matsumoto, K Leigh Greathouse, Tomer Cooks, et al. Acidovorax temperans skews neutrophil maturation and polarizes Th17 cells to promote lung adenocarcinoma development. Oncogenesis. 2024. 13. 1. 13-13
Takehiro Tozuka, Rintaro Noro, Keisuke Yoshida, Satoshi Takahashi, Mariko Hirao, Kuniko Matsuda, Yasuhiro Kato, Shinji Nakamichi, Susumu Takeuchi, Masaru Matsumoto, et al. Phosphoproteomic Analysis Identified Mutual Phosphorylation of FAK and Src as a Mechanism of Osimertinib Resistance in EGFR-Mutant Lung Cancer. JTO clinical and research reports. 2024. 5. 4. 100668-100668
Yang Yunchu, Akihiko Miyanaga, Kuniko Matsuda, Koichiro Kamio, Masahiro Seike. Exploring effective biomarkers and potential immune related gene in small cell lung cancer. Scientific reports. 2024. 14. 1. 7604-7604

ｍore...

MISC (256)：

磯博和, 宮永晃彦, 戸塚猛大, 武内進, 中道真仁, 松本優, 齋藤好信, 清家正博. 当院における間質性肺疾患合併癌性胸膜炎に対する胸膜癒着術の後方視的検討. 日本医科大学医学会雑誌. 2023. 19. 4. 408-408
松本優, 峯岸裕司, 比嘉克行, 福泉彩, 恩田直美, 武内進, 宮永晃彦, 野呂林太郎, 笠原寿郎, 清家正博. 特発性間質性肺炎合併小細胞肺癌に対するカルボプラチン+エトポシド療法の忍容性を評価する第II相試験. 肺癌. 2023. 63. 5. 475-475
寺嶋勇人, 松本優, 飯田博紀, 高嶋紗衣, 福泉彩, 武内進, 宮永晃彦, 笠原寿郎, 寺崎泰弘, 清家正博. 当院におけるTTF-1陽性非扁平上皮肺癌のTTF-1発現率と複合免疫療法の治療効果に関する後方視的検討. 肺癌. 2023. 63. 5. 620-620
加藤泰裕, 松本優, 高野夏希, 平尾真季子, 松田久仁子, 戸塚猛大, 恩田直美, 中道真仁, 武内進, 宮永晃彦, et al. HMGCS2によるメバロン酸経路を介したNTRK阻害薬に対する耐性誘導とその克服(HMGCS2 Induces resistance to NTRK inhibitors via mevalonate pathway). 日本癌学会総会記事. 2023. 82回. 421-421
山川美早紀, 武内進, 寺嶋勇人, 柏田建, 深澤美樹, 松本優, 林俊行, 宮永晃彦, 笠原寿郎, 清家正博. 限局型小細胞肺癌に合併したLambert-Eaton症候群対し,細胞傷害性抗癌薬と抗コリンエステラーゼ阻害薬で早期症状改善を得た1例. 日本内科学会関東地方会. 2023. 686回. 50-50

ｍore...

Professional career (1)：

博士(医学) (日本医科大学)

Work history (3)：

2021/10 - 現在 Nippon Medical School Department of Pulmonary Medicine and Oncology, Graduate School of Medicine
2015 - 2021/09 Nippon Medical School Graduate School
2001/03 - Nippon Medical School

Committee career (1)：

2024/02 - 日本呼吸器学会代議員

Awards (4)：

2018/04 - 日本医科大学同窓会医学研究助成
2013/11 - 東京呼吸病態研究会研究奨励賞
2013/09 - 日本医科大学丸山記念助成
2011/09 - 日本医科大学丸山研究助成

Association Membership(s) (9)：

Internal Association for the Study of Lung Cancer , American Association of Cancer Research , THE JAPAN SOCIETY FOR RESPIRATORY ENDOSCOPY , THE JAPAN LUNG CANCER SOCIETY , THE JAPANESE CANCER ASSOCIATION , JAPAN SOCIETY OF CLINICAL ONCOLOGY , Japanese society of medical oncology , THE JAPANESE RESPIRATORY SOCIETY , THE JAPANESE SOCIETY OF INTERNAL MEDICINE

※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page